IDEAYA Biosciences, Inc. (IDYA) stock

IDYANasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 9/309% above fair value

$31.83+0.34 (+1.08%)

Close on Nov 13, 2026Market cap $3.07BP/E –Yield –

IDEAYA Biosciences EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

IDEAYA Biosciences has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

Parsed from the XBRL in IDEAYA Biosciences's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is IDYA.

Operating margin-92.7% · median 11.3%

Net margin-74.8% · median 10.3%

Advertisement
300 × 250

See a number that looks wrong?